Ursodeoxycholic acid in neonatal hepatitis and infantile paucity of intrahepatic bile ducts: Review of a historical cohort

Digestive Diseases and Sciences

Volumn 54, Issue 10, 2009, Pages 2231-2241

  Kotb, M A ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

Cholestasis; Neonatal hepatitis; Paucity of intrahepatic bile ducts; UDCA; Ursodeoxycholic acid; Vanishing bile duct syndrome

Indexed keywords

ALPHA TOCOPHEROL; COLESTYRAMINE; RETINOL; URSODEOXYCHOLIC ACID; VITAMIN D; VITAMIN K GROUP;

ABSCESS; ARTICLE; ASCITES; BACTERIAL PERITONITIS; BILE DUCT DISEASE; BILE DUCT MALFORMATION; BLEEDING TENDENCY; BRONCHITIS; BRONCHOPNEUMONIA; CHILD; CHOLESTASIS; CONTROLLED STUDY; COUGHING; CYANOSIS; DIARRHEA; DISEASE ASSOCIATION; DISEASE COURSE; DRUG ERUPTION; DRUG FEVER; DYSURIA; EGYPT; FEMALE; GALLSTONE FORMATION; HEMOLYTIC ANEMIA; HUMAN; HYPERCHOLESTEROLEMIA; INFANT; INTRAHEPATIC BILE DUCT; INTRAHEPATIC BILE DUCT PAUCITY; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NEWBORN HEPATITIS; OTITIS MEDIA; OUTCOME ASSESSMENT; PHARYNGITIS; PNEUMONIA; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; PRURITUS; RHINITIS; THORAX DISEASE; THRUSH; TREATMENT DURATION; TREATMENT RESPONSE; VOMITING;

BILE DUCTS, INTRAHEPATIC; CHOLESTASIS; FEMALE; HEPATITIS; HUMANS; INFANT, NEWBORN; MALE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; URSODEOXYCHOLIC ACID;

EID: 70149103745     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-008-0600-8     Document Type: Article

References (46)

1. Desmet VJ, Callea F. Cholestatic syndromes of infancy and childhood. In: Zakim D, Boyer TD, eds. Hepatology: A Textbook of Liver Disease. 3rd ed. Philadelphia: WB Saunders; 1996:1649-1698.
2. Kader HH, Balistreri WF. Cholestasis. In: Beherman RE, Kleigmen RM, Jenson HB, eds. Nelson Textbook of Pediatrics. 17th ed. Philadelphia: WB Saunders; 2004:1314-1319.
3. AR Crawford XZ Lin JM Crawford 1998 The normal adult liver biopsy: a quantitative reference standard Hepatology 28 323 331 10.1002/hep.510280206 (Pubitemid 28363655)
4. J Ludwig RH Wiesner NF La Russo 1998 Idiopathic adulthood ductopenia. A cause of chronic cholestastic liver disease and biliary cirrhosis J Hepatol 17 193 199
5. Portmann BC, Nakanuma Y. Diseases of the bile ducts. In: Burt AD, Portmann BC, Ferrel LD, eds. MacSween's Pathology of the Liver. 5th ed. Philadelphia: Churchill Livingstone Elsevier; 2007:517-581.
6. D Alagille A Estrada M Hadchouel M Gautier M Odievre JP Dommergues 1987 Syndromic paucity of intralobular bile ducts Alagille syndrome or arteriohepatic dysplasia: Review of 80 cases J Pediatr 110 195 200 10.1016/S0022-3476(87) 80153-1 (Pubitemid 17016845)
7. VJ Desmet 1997 Vanishing bile duct syndrome in drug-induced liver disease J Hepatol 26 suppl 1 31 35 10.1016/S0168-8278(97)82330-6
8. U Tannuri MC Velhote MM Santos, et al. 2004 Pediatric liver transplantation: fourteen years of experience at the children institute in Sao Paulo, Brazil Transplant Proc 36 941 942 10.1016/j.transproceed.2004.03.101 (Pubitemid 38766231)
9. LR Hagey DL Crombie E Espinosa MC Carey H Igimi AF Hofmann 1993 Ursodeoxycholic acid in the Ursidae: biliary bile acids of bears, pandas, and related carnivores J Lipid Res 34 1911 1917
10. AF Hofmann 1994 Pharmacology of ursodeoxycholic acid, an enterohepatic drug Scand J Gastroenterol 204 suppl 1 15 10.3109/00365529409103618
11. WH Bachrach AF Hofmann 1982 Ursodeoxycholic acid in the treatment of cholesterol cholelithiasis. Part I Dig Dis Sci 27 737 761 10.1007/BF01393771
12. U Leuschner M Leuschner J Sieratzki W Kurtz K Hübner 1985 Gallstone dissolution with ursodeoxycholic acid in patients with chronic active hepatitis and two years follow-up. A pilot study Dig Dis Sci 30 642 649 10.1007/BF01308413 (Pubitemid 15045039)
13. C Degott ES Zafrani P Callard B Balkau RE Poupon R Poupon 1999 Histopathological study of primary biliary cirrhosis and the effect of ursodeoxycholic acid treatment on histology progression Hepatology 29 4 1007 1012 10.1002/hep.510290444 (Pubitemid 29168729)
14. EJ Heathcote K Cauch-Dudek V Walker, et al. 1994 The Canadian multicentre double blind randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosis Hepatology 19 1149 1156
15. J Reichen 2008 Review: ursodeoxycholic acid does not reduce risk for mortality or liver transplantation in primary cirrhosis ACP J Club 148 1 17
16. G Dinler N Koçak A Yüce F Gürakan H Ozen 1999 Ursodeoxycholic acid in children with cholestatic liver disease Turk J Pediatr 41 1 91 98 Abstract (Pubitemid 29104440)
17. CF [tmp] McEvoy FJ Suchy 1996 Biliary tract disease in children Pediatr Clin North Am 43 75 98 10.1016/S0031-3955(05)70398-9 (Pubitemid 26073542)
18. Eastwood GL, Avunduk C. Gall stones. In: Eastwood GL, Avunduk C, eds. Manual of Gastroenterology. 2nd ed. New York: Little and Brown; 1994:333-343.
19. Gal P, Reed MD. Medications. In: Beherman RE, Kleigmen RM, Jenson HB, eds. Nelson Textbook of Pediatrics. 17th ed. Philadelphia: WB Saunders; 2004:2432-2501.
20. M Odièvre M Hadchouel P Landrieu D Alagille N Eliot 1981 Longterm prognosis for infants with intrahepatic cholestasis and patent extrahepatic biliary tract Arch Dis Child 56 373 376
21. +(BKCa) channel activity in smooth muscle cells J Gen Physiol 119 251 273 10.1085/jgp.119.3.251 (Pubitemid 34522239)
22. C Weitzel D Stark F Kullmann J Schölmerich A Holstege W Falk 2005 Ursodeoxycholic acid induced activation of the glucocorticoid receptor in primary rat hepatocytes Eur J Gastroenterol Hepatol 17 169 177 10.1097/00042737-200502000-00007 (Pubitemid 40349530)
23. F Arenas I Hervias M Uriz R Joplin J Prieto JF Medina 2008 Combination of ursodeoxycholic acid and glucocorticoids upregulates the AE2 alternate promoter in human liver cells J Clin Invest 118 2 695 709
24. ME Miller R Stieheim 1973 Phagocytic, opsonic and immunoglobulin studies in newborns Calif Med 119 2 43 63
25. DB Lewis CC Yu J Meyer BK English SJ Kahn CB Wilson 1991 Cellular and molecular mechanisms for reduced interleukin 4 and interferon y production by neonatal T cells J Clin Invest 87 194 202 10.1172/JCI114970
26. Lewis JH, Kliener DE. Hepatic injury due to drugs, chemicals and toxins. In: Burt AD, Portmann BC, Ferrel LD, eds. MacSween's Pathology of the liver. 5th ed. Philadelphia: Churchill Livingstone Elsevier; 2007:649-759.
27. J Kirby KW Heaton JL Burton 1974 Pruritic effect of bile salts BMJ 4 693 695
28. P Fickert M Trauner A Fuchsbichler C Stumptner K Zatloukal H Denk 2002 Cytokeratins as targets for bile acid-induced toxicity Am J Pathol 160 2 491 599
29. AF Hofmann 1999 The continuing importance of bile acids in liver and intestinal disease Arch Intern Med 159 2647 2658 10.1001/archinte.159.22.2647
30. A Ortiz C Lorz P Justo MP Catalán J Egido 2001 Contribution of apoptotic cell death to renal injury J Cell Mol Med 5 1 18 32 10.1111/j.1582-4934.2001.tb00135.x
31. C Guyot C Combe C Balabaud P Bioulac-Sage A Desmoulière 2007 Fibrogenic cell fate during fibrotic tissue remodeling observed in rat and human cultured liver slices J Hepatol 46 1 142 150 10.1016/j.jhep.2006.08.013 (Pubitemid 44834429)
32. M Trauner IW Graziadei 1999 Review article: mechanisms of action and therapeutic applications of ursodeoxycholic acid in chronic liver diseases Aliment Pharmacol Ther 13 979 996 10.1046/j.1365-2036.1999.00596.x (Pubitemid 29374097)
33. KN Lazaridis GJ Gores KD Lindor 2001 Ursodeoxycholic acid mechanisms of action and clinical use in hepatobiliary disorders J Hepatol 35 134 146 10.1016/S0168-8278(01)00092-7 (Pubitemid 32646237)
34. Corpechot C, Poujol-Robert A, Wendum D, Galotte M, Chretien Y, Poupon RE, Poupon R. Biochemical markers of liver fibrosis and lymphocytic piecemeal necrosis in UDCA-treated patients with primary biliary cirrhosis. Liver Int. 2004;24(3):187-193.
35. C Gluud E Christensen 2008 Ursodeoxycholic acid for primary biliary cirrhosis Cochrane Database Syst Rev 16 3 CD000551
36. MJ Mayo 2005 Patients and patience: the pitfalls of primary biliary cirrhosis trials Nat Clin Pract Gastroenterol Hepatol 2 552 553 10.1038/ncpgasthep0360
37. M Kotb 2008 Review of historical cohort: ursodeoxycholic acid in extrahepatic biliary atresia J Ped Surg 43 7 1321 1327 10.1016/j.jpedsurg.2007. 11.043 (Pubitemid 351981990)
38. A Michaels C Levy 2008 The medical management of primary sclerosing cholangitis Medscape J Med 10 3 61
39. U Beuers GU Denk CJ Soroka 2003 Taurolithocholic acid exerts cholestatic effects via phosphatidylinositol 3-kinase-dependent mechanisms in perfused rat livers and rat hepatocyte couplets J Biol Chem 278 17810 17818 10.1074/jbc.M209898200 (Pubitemid 36799385)
40. P Fickert A Fuchsbichler HU Marschall, et al. 2006 Lithocholic acid feeding induces segmental bile duct obstruction and destructive cholangitis in mice Am J Pathol 168 2 410 422 10.2353/ajpath.2006.050404 (Pubitemid 43271140)
41. J Shoda R Mahara T Osuga, et al. 1988 Similarity of unusual bile acids in human umbilical cord blood and amniotic fluid from newborns and in sera and urine from adult patients with cholestatic liver diseases J Lipid Res 29 847 858
42. AF Hofmann 2004 Detoxification of lithocholic acid, a toxic bile acid relevance to drug hepatotoxicity Drug Metab Rev 36 703 722 10.1081/DMR-200033475 (Pubitemid 39453070)
43. H Takikawa T Beppu Y Seyama K Obinata H Nittono 1985 Serum concentration of glucuronidated and sulfated bile acids in children with cholestasis Biochem Med 33 381 386 10.1016/0006-2944(85)90014-6 (Pubitemid 15044094)
44. G Paumgartner U Beuers 2002 Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited Hepatology 36 525 531 10.1053/jhep.2002.36088 (Pubitemid 34977162)
45. F Bazzoli A Roda H Fromm RP Sarva E Roda L Barbara 1982 Relationship between serum and biliary bile acids as an indicator of chenodeoxycholic and ursodeoxycholic acid-induced hepatotoxicity in the rhesus monkey Dig Dis Sci 27 5 417 424 10.1007/BF01295650
46. Y Koga 1987 Anti-cholestatic and cytoprotective properties of ursodeoxycholic acid. Studies in vivo and in vitro Acta Hepatol Jpn 28 1597 1604